Find-A-Study

A Phase 2a, Open-label, Pilot Study to Evaluate Efficacy, Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of MYK-224 in Participants with Symptomatic Hypertrophic Cardiomyopathy and Left Ventricular Outflow Tract Obstruction

Purpose

Category

Heart, Vascular and Blood

IRB Number: 20220477HU
NCT Number: -
Open to Enrollment: Yes
Sponsor: -

Study Contact

Principal Investigator
Allen Anderson

Andrea Hansis-diarte
+1 (210) 617-5300
hansisdiarte@uthscsa.edu

Johnnie Jones
(210) 450-7277
jonesj21@uthscsa.edu

Lorannys Sanchez Tamarez
(210) 450-8332
sancheztamar@uthscsa.edu

Eligibility

Eligible Ages
Eligible Genders
Accepts Healthy Volunteers: No

Inclusion Criteria

Exclusion Criteria

Study Design

Arm Groups